Filing Details
- Accession Number:
- 0000899243-20-015413
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-05 16:06:03
- Reporting Period:
- 2020-06-03
- Accepted Time:
- 2020-06-05 16:06:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1731831 | Eidos Therapeutics Inc. | EIDX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1655016 | C Jonathan Fox | C/O Eidos Therapeutics, Inc. 101 Montgomery Street, Suite 2000 San Francisco CA 94104 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-05-31 | 444 | $41.57 | 3,294 | No | 5 | A | Direct | |
| Common Stock | Disposition | 2020-06-01 | 1,020 | $0.00 | 397,605 | No | 5 | G | Indirect | See footnote |
| Common Stock | Disposition | 2020-06-02 | 1,020 | $0.00 | 396,585 | No | 5 | G | Indirect | See footnote |
| Common Stock | Disposition | 2020-06-03 | 5,000 | $50.00 | 391,585 | No | 4 | S | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | A | Direct | |
| No | 5 | G | Indirect | See footnote |
| No | 5 | G | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
Footnotes
- Shares acquired pursuant to the Issuer's 2018 Employee Stock Purchase Plan.
- The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2020.
Billionaire Hedge Funds
